Management Experiences of Post-Gastrectomy Severe Alkaline Reflux Esophagitis.


Journal

The American surgeon
ISSN: 1555-9823
Titre abrégé: Am Surg
Pays: United States
ID NLM: 0370522

Informations de publication

Date de publication:
Nov 2023
Historique:
medline: 6 12 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: ppublish

Résumé

Alkaline reflux esophagitis is a recognized complication of procedures that compromise the lower esophageal sphincter (LES), including gastrectomy. Incidence of reflux is dependent on the reconstructive procedure, with Roux-en-Y (RY) esophagojejunostomy commonly accepted as the optimal method. The authors report their experience of 5 patients who underwent remedial intervention for severe alkaline reflux esophagitis following gastric cancer surgery, over a 6-year period (2014-2020). Primary diagnoses encompassed 4 gastric adenocarcinomas and 1 gastric neuroendocrine tumor. Four patients previously underwent total gastrectomy and 1 subtotal gastrectomy with RY reconstruction. Onset of postoperative reflux symptoms ranged from 2 weeks to 3 years. Failing medical management, all patients underwent jejunojejunal anastomosis and Roux limb length revision with surgical jejunostomy. At follow-up, 4 out of 5 patients had some degree of symptom resolution and one with unresolved symptoms. The authors report our experience of managing this complication following gastrectomy with jejunojejunal anastomosis and Roux limb length revision.

Identifiants

pubmed: 37449920
doi: 10.1177/00031348231189831
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5012-5016

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Hugo C Temperley (HC)

National Oesophagogastric Cancer Centre, Trinity St James Cancer Institute, St James's Hospital, Dublin, Ireland.

Eimear Phoenix (E)

National Oesophagogastric Cancer Centre, Trinity St James Cancer Institute, St James's Hospital, Dublin, Ireland.
Royal College of Surgeons of Ireland, Dublin, Ireland.

Caitlin Waters (C)

National Oesophagogastric Cancer Centre, Trinity St James Cancer Institute, St James's Hospital, Dublin, Ireland.

Joseph Hanna (J)

St. John of God Hospital, Subiaco, Perth, Western Australia.

Michelle Fanning (M)

Department of Clinical Nutrition St James's Hospital, Dublin 8, Ireland.

Noel E Donlon (NE)

National Oesophagogastric Cancer Centre, Trinity St James Cancer Institute, St James's Hospital, Dublin, Ireland.
Royal College of Surgeons of Ireland, Dublin, Ireland.

John V Reynolds (JV)

National Oesophagogastric Cancer Centre, Trinity St James Cancer Institute, St James's Hospital, Dublin, Ireland.

Claire L Donohoe (CL)

National Oesophagogastric Cancer Centre, Trinity St James Cancer Institute, St James's Hospital, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH